scholarly journals Twin studies of subjective sleep quality and sleep duration, and their behavioral correlates: Systematic review and meta-analysis of heritability estimates

2020 ◽  
Vol 109 ◽  
pp. 78-89 ◽  
Author(s):  
Juan J Madrid-Valero ◽  
María Rubio-Aparicio ◽  
Alice M. Gregory ◽  
Julio Sánchez-Meca ◽  
Juan R. Ordoñana
2021 ◽  
pp. 019459982110295
Author(s):  
Jacob Fried ◽  
Erick Yuen ◽  
Kathy Zhang ◽  
Andraia Li ◽  
Nicholas R. Rowan ◽  
...  

Objective To determine the impact of treatment for patients with nasal obstruction secondary to allergic rhinitis (AR) and nasal septal deviation (NSD) on sleep quality. Data Sources Primary studies were identified though PubMed, Scopus, Cochrane Library, and Web of Science. Review Methods A systematic review was performed by querying databases for articles published through August 2020. Studies were included that reported on objective sleep parameters (apnea-hypopnea index) and sinonasal and sleep-specific patient-reported outcome measures: Rhinoconjunctivitis Quality of Life Questionnaire, Nasal Obstruction Symptom Evaluation, Epworth Sleepiness Scale (EpSS), and Pittsburgh Sleep Quality Index (PSQI). Results The database search yielded 1414 unique articles, of which 28 AR and 7 NSD studies were utilized for meta-analysis. A total of 9037 patients (8515 with AR, 522 with NSD) were identified with a mean age of 35.0 years (35.3 for AR, 34.0 for NSD). Treatment for AR and NSD significantly improved subjective sleep quality. For AR, the EpSS mean difference was −1.5 (95% CI, –2.4 to –0.5; P = .002) and for the PSQI, –1.7 (95% CI, –2.1 to –1.2; P < .00001). For NSD, the EpSS mean difference was −3.2 (95% CI, –4.2 to –2.2; P < .00001) and for the PSQI, –3.4 (95% CI, –6.1 to –0.6; P = .02). Conclusion Subjective sleep quality significantly improved following treatment for AR and NSD. There were insufficient data to demonstrate that objective metrics of sleep quality similarly improved.


2020 ◽  
Author(s):  
ling wang ◽  
Feng Jin

Abstract Background : To assess the association of sleep duration and quality with the risk of preterm birth. Methods : Relevant studies were retrieved from the PubMed and Web of Science databases up to September 30, 2018. The reference lists of the retrieved articles were reviewed. Random effects models were applied to estimate summarized relative risks (RRs) and 95% confidence intervals (CIs). Results : Ten identified studies (nine cohort studies and one case-controlled study) examined the associations of sleep duration and quality with the risk of preterm birth. As compared with women with the longest sleep duration, the summary RR was 1.23 (95% CI = 1.01–1.50) for women with the shortest sleep duration, with moderate between-study heterogeneity ( I 2 = 57.4%). Additionally, as compared with women with good sleep quality, the summary RR was 1.54 (95% CI = 1.18–2.01) for women with poor sleep quality (Pittsburgh Sleep Quality Index > 5), with high between-study heterogeneity ( I 2 = 76.7%). Funnel plots as well as the Egger’s and Begg’s tests revealed no evidence of publication bias. Conclusions : This systematic review and meta-analysis revealed that short sleep duration and poor sleep quality may be associated with an increased risk of preterm birth. Further subgroup analyses are warranted to test the robustness of these findings as well as to identify potential sources of heterogeneity.


2018 ◽  
Vol 20 (3) ◽  
pp. 592-605 ◽  
Author(s):  
Kenneth Lo ◽  
Brigitte Woo ◽  
Martin Wong ◽  
Wilson Tam

2019 ◽  
Vol 8 (12) ◽  
pp. 2156 ◽  
Author(s):  
Jacobo Á. Rubio-Arias ◽  
Raquel Rodríguez-Fernández ◽  
Luis Andreu ◽  
Luis M. Martínez-Aranda ◽  
Alejandro Martínez-Rodriguez ◽  
...  

Sarcopenia is an age-related condition. However, the prevalence of sarcopenia may increase due to a range of other factors, such as sleep quality/duration. Therefore, the aim of the study is to conduct a systematic review with meta-analysis to determine the prevalence of sarcopenia in older adults based on their self-reported sleep duration. Methods: Three electronic databases were used—PubMed-Medline, Web of Science, and Cochrane Library. We included studies that measured the prevalence of sarcopenia, divided according to sleep quality and excluded studies (a) involving populations with neuromuscular pathologies, (b) not showing prevalence values (cases/control) on sarcopenia, and (c) not including classificatory models to determine sleep quality. Results: high prevalence values in older adults with both long and short sleep duration were shown. However, prevalence values were higher in those with inadequate sleep (<6–8 h or low efficiency) (OR 0.76; 95% CI (0.70–0.83); Q = 1.446; p = 0.695; test for overall effect, Z = 6.01, p < 0.00001). Likewise, higher prevalence levels were shown in men (OR 1.61; 95% CI (0.82–3.16); Q = 11.80; p = 0.0189) compared to women (OR 0.77; 95% CI (0.29–2.03); Q = 21.35; p = 0.0003). Therefore, the prevalence of sarcopenia appears to be associated with sleep quality, with higher prevalence values in older adults who have inadequate sleep.


2021 ◽  
pp. postgradmedj-2020-139319
Author(s):  
Vicky Chan ◽  
Kenneth Lo

PurposeDifferent dietary supplements aimed at improving sleep quality are available on the market, but there has not been a comprehensive review to evaluate the efficacy of these dietary supplements on subjective sleep quality. We aimed to summarise up-to-date research evidence and to identify the types of dietary supplement that improve subjective sleep quality.MethodsMultiple databases (Ovid Emcare, Ovid MEDLINE (R) and Epub Ahead of Print, In-Process & Other Non-Indexed Citations and APA PsycInfo) were used for searching papers published until August 2020. The changes in sleep quality indices, intervention duration and sample size were extracted from every paper. To analyse the effect of dietary supplements on sleep quality, a random effects model with mean difference (MD) and 95% CI was adopted. The heterogeneity across studies was measured by I2 statistics. The quality of included studies was evaluated by Cochrane’s risk of bias tool.ResultsThirty-one randomised controlled trials of dietary supplements were included. Subjective sleep quality was significantly improved by supplementation of amino acids (MD −1.27, 95% CI −2.35 to –0.20; I2=0%), melatonin (MD −1.21, 95% CI −2.17 to –0.24; I2=79%) and vitamin D (MD −1.63, 95% CI −3.15 to –0.10; I2=85%). Although not all studies provided adequate data for meta-analysis, we also discussed how magnesium, zinc, resveratrol and nitrate supplementation may improve sleep quality.ConclusionsAmino acids, vitamin D and melatonin supplements were significantly beneficial to improve sleep quality. However, high heterogeneity and wide confidence levels were observed in vitamin D and melatonin. Further research on the effect of magnesium, zinc, resveratrol and nitrate supplementation on improving sleep quality is required.


BMJ Open ◽  
2017 ◽  
Vol 7 (12) ◽  
pp. e018585 ◽  
Author(s):  
Marlot Kruisbrink ◽  
Wendy Robertson ◽  
Chen Ji ◽  
Michelle A Miller ◽  
Johanna M Geleijnse ◽  
...  

ObjectivesTo assess the longitudinal evidence of the relationships between sleep disturbances (of quantity and quality) and dyslipidaemia in the general population and to quantify such relationships.SettingSystematic review and meta-analysis following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.MethodsWe performed a systematic search of PubMed and Embase (up to 9 September 2017), complemented with manual searches, of prospective population studies describing the association between sleep duration and quality and the incidence of dyslipidaemias. Relative risks (95% CIs) were extracted and pooled using a random effects model. Subgroup analyses by lipid type were performed. Heterogeneity and publication bias were also assessed. Quality was assessed with Downs and Black score.ParticipantsStudies were included if they were prospective, had measured sleep quantity and/or quality at baseline and either incident cases of dyslipidaemia or changes in blood lipid fractions assessed prospectively.Primary outcome measuresIncidence of dyslipidaemia and changes in lipid fractions. Dyslipidaemia was defined as a high total cholesterol, triglycerides, low-density lipoprotein cholesterol or low high-density lipoprotein cholesterol compared with the reference group.ResultsThirteen studies were identified (eight using sleep duration, four sleep quality and one both). There was heterogeneity in the sleep quality aspects and types of lipids assessed. Classification of sleep duration (per hour/groups) also varied widely. In the pooled analysis of sleep duration (6 studies, 16 cohort samples; 30 033 participants; follow-up 2.6–10 years), short sleep was associated with a risk of 1.01 (95% CI 0.93 to 1.10) of developing dyslipidaemia, with moderate heterogeneity (I2=56%, P=0.003) and publication bias (P=0.035). Long sleep was associated with a risk of 0.98 (95% CI 0.87 to 1.10) for dyslipidaemia, with heterogeneity (I2=63%, P<0.001) and no significant publication bias (P=0.248).ConclusionThe present analysis was unable to find supportive evidence of a significant relationship between sleep duration and the development of dyslipidaemia. However, heterogeneity and small number of studies limit the interpretation.PROSPERO registration numberCRD42016045242.


Author(s):  
Evan Winiger ◽  
Leah Hitchcock ◽  
Angela Bryan ◽  
Cinnamon Bidwell

Objectives: Estimate the associations between cannabis use with expectations of cannabis being a sleep aid, subjective sleep outcomes, and the influence of age on these relationships. Methods: In 152 moderate cannabis users (67% female, mean age = 31.45, SD = 12.96, age range = 21-70) we assessed the influence of cannabis use history and behaviors on expectations of cannabis being a sleep aid and subjective sleep outcomes via the Pittsburgh Sleep Quality Index (PSQI). We used moderation analysis to examine the role of age in the relationship between cannabis use and subjective sleep outcomes. Results: Cannabis use along with more frequent cannabis use were associated with increased expectations that cannabis use improves sleep (all β > 0.03, p < 0.04). Frequency of recent cannabis use and reported average THC or CBD concentration were largely not associated with subjective sleep outcomes. However, endorsing current cannabis use was associated with worse subjective sleep quality (β = 1.34, p = 0.02) and increased frequency of consuming edibles was associated with worse subjective sleep efficiency (β = 0.03, p = 0.04), lower sleep duration (β = 0.03, p = 0.01), and higher global PSQI scores (worse overall sleep) (β = 0.10, p = 0.01). Furthermore, age was determined to have a moderating influence on the relationship between increased concentration of CBD and both better sleep duration and sleep quality (both p < 0.03). Conclusion: Cannabis users have higher expectations of cannabis being a sleep aid, but few associations existed between cannabis use and subjective sleep outcomes with the exceptions of endorsing any cannabis use and frequency of edible use. Additionally, age may be an important moderator of the potential positive influence CBD concentration can have on sleep.


2020 ◽  
Author(s):  
Teresa Arora ◽  
Asma Alamoodi ◽  
Ian Grey ◽  
Linda Östlundh ◽  
Omar M. Omar ◽  
...  

Abstract Background: Mental resilience has emerged as a recent focus within the context of positive psychology. Resilience is a potentially modifiable construct. Some preliminary evidence from experimental studies as well as clinical populations has indicated that sleep may be related to mental resilience, but little is known about this relationship in healthy populations. Sleep is a complex with multi-factorial outcome, although the majority of research effort has focused on sleep duration and sleep quality. Our systematic review and meta-analysis will identify original research data from observational studies to assess if sleep duration and/or sleep quality is associated with levels of psychological resilience amongst healthy children, adolescents and adults. We hypothesize that there will be a positive association between sleep duration/quality and mental resilience across all age groups. Methods: A comprehensive, systematic search for literature will be conducted in June 2020 (LÖ), covering a total of eight academic databases (PubMed, Embase, PsycInfo, PsycArticles, CINAHL, Scopus, Web of Science and Academic Search Complete). Sources for grey materials will also be included and experts in the field will also be contacted for inclusion of unpublished data. PubMed and PubMed’s MeSH terms were used to develop the search strategy and systematically identify relevant search terms. Two authors (IG & AA) will screen the articles independently, and a third researcher (TA) will resolve discrepancies. The primary outcome is mental/psychological resilience. The systematic review will adhere to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.Discussion: The results of our systematic review and meta-analysis are intended to be published in an appropriate scientific peer-reviewed journal and will be made publicly available. The findings from our project are envisioned to inform and educate the public as well as healthcare and education systems, globally. Our systematic review protocol has been peer-reviewed and is currently registered in the international database, PROSPERO.Systematic review registration: CRD42020191119 (submitted on 2 July 2020).


2021 ◽  
Author(s):  
Immanuel Babu Henry Samuel ◽  
Charity B Breneman ◽  
Timothy Chun ◽  
Arghavan Hamedi ◽  
Rayelynn Murphy ◽  
...  

ABSTRACT Introduction Traumatic brain injury (TBI) or concussion is a known risk factor for multiple adverse health outcomes, including disturbed sleep. Although prior studies show adverse effects of TBI on sleep quality, its compounding effect with other factors on sleep is unknown. This meta-analysis aimed to quantify the effects of TBI on subjective sleep quality in the context of military status and other demographic factors. Materials and Methods A programmatic search of PubMed database from inception to June 2020 was conducted to identify studies that compared subjective sleep quality measured using Pittsburgh Sleep Quality Index (PSQI) in individuals with TBI relative to a control group. The meta-analysis included group-wise standard mean difference (SMD) and 95% CI. Pooled means and SDs were obtained for TBI and non-TBI groups with and without military service, and meta-regression was conducted to test for group effects. Exploratory analysis was performed to test for the effect of TBI, non-head injury, military status, sex, and age on sleep quality across studies. Results Twenty-six articles were included, resulting in a combined total of 5,366 individuals (2,387 TBI and 2,979 controls). Overall, individuals with TBI self-reported poorer sleep quality compared to controls (SMD = 0.63, 95% CI: 0.45 to 0.80). Subgroup analysis revealed differences in the overall effect of TBI on PSQI, with a large effect observed in the civilian subgroup (SMD: 0.80, 95% CI: 0.57 to 1.03) and a medium effect in the civilian subgroup with orthopedic injuries (SMD: 0.40, 95% CI: 0.13 to 0.65) and military/veteran subgroup (SMD: 0.43, 95% CI: 0.14 to 0.71). Exploratory analysis revealed that age and history of military service significantly impacted global PSQI scores. Conclusions Poor sleep quality in TBI cohorts may be due to the influence of multiple factors. Military/veteran samples had poorer sleep quality compared to civilians even in the absence of TBI, possibly reflecting unique stressors associated with prior military experiences and the sequelae of these stressors or other physical and/or psychological traumas that combine to heightened vulnerability. These findings suggest that military service members and veterans with TBI are particularly at a higher risk of poor sleep and its associated adverse health outcomes. Additional research is needed to identify potential exposures that may further heighten vulnerability toward poorer sleep quality in those with TBI across both civilian and military/veteran populations.


2020 ◽  
Vol 10 (3) ◽  
pp. 64 ◽  
Author(s):  
Sebastian Butz ◽  
Dagmar Stahlberg

Poor sleep quality is highly prevalent in modern societies and negatively linked to various health outcomes. While previous research has demonstrated preliminary evidence for self-compassion as a tool for improving sleep quality, this review provides a meta-analysis of respective published and unpublished results of our own research group using German samples. A total of nine studies are included (N = 956 participants), consisting of both correlational and experimental data. Across these studies, there was a medium correlation between self-compassion and subjective sleep quality, r = 0.303, 95% CI (0.244; 0.360). In three experimental studies, a small increase in participants’ self-reported sleep quality emerged, in comparison to control conditions, Hedges’ s g = 0.484, 95% CI (0.148; 0.821). Limitations on study level concern both the small sample sizes and short-term analyses of intervention effects. As a conclusion, this review supports both the correlational and causal relationship between self-compassion and increased subjective sleep quality across diverse operationalizations and samples. Future research should focus on the moderating effects of intervention type, duration of intervention effects, and type of target population.


Sign in / Sign up

Export Citation Format

Share Document